LifeStance Health Q1 revenue beats estimates, raises outlook

LifeStance Health

07/05/2026 11:14

Overview

US outpatient mental healthcare provider's Q1 revenue rose 21%, beating analyst expectations

Adjusted EBITDA for Q1 rose 48% and beat analyst expectations

Company raised full-year 2026 revenue and profit outlook

Outlook

Lifestance Health raises 2026 revenue guidance to $1.640 bln-$1.680 bln

Company expects 2026 Center Margin of $547 mln-$571 mln

Lifestance Health sees 2026 Adjusted EBITDA of $200 mln-$220 mln

Company expects Q2 2026 revenue of $405 mln-$425 mln

Lifestance Health expects Q2 2026 Adjusted EBITDA of $50 mln-$60 mln

Result Drivers

VISIT VOLUME GROWTH - Higher visit volumes, up 18% year-over-year, drove revenue growth

CLINICIAN BASE EXPANSION - Net clinician base grew 11% to 8,349, supporting increased patient visits

HIGHER REVENUE PER VISIT - Improved clinician productivity and higher total revenue per visit contributed to revenue growth

Company press release: ID:nGNXbkYdLH

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Beat
$403.50 mln
$387.37 mln (8 Analysts)
Q1 EPS
$0.04
Q1 Net Income
$14.20 mln
Q1 Adjusted EBITDA
Beat
$51.10 mln
$42.39 mln (8 Analysts)

Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the healthcare facilities & services peer group is "buy"

Wall Street's median 12-month price target for LifeStance Health Group Inc is $10.00, about 35.9% above its May 6 closing price of $7.36

The stock recently traded at 74 times the next 12-month earnings vs. a P/E of 170 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)